NOVOCURE DRN financial statements, including revenue, expenses, profit, and loss

The total revenue of N2VC34 for the last quarter is 695.99 M BRL, and it's 7.01% higher compared to the previous quarter. The net income of Q1 24 is -194.77 M BRL.